Table 3.
Parameter | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
P | HR | 95% CI | P | HR | 95% CI | |
Age | ||||||
< 50 vs. ≧50 | 0.093 | 0.401 | 0.138–1.165 | |||
Family history of tumor | ||||||
Negative vs. positive | 0.279 | 0.325 | 0.043–2.487 | |||
Education | ||||||
< Graduation vs. ≧graduation | 0.298 | 26.921 | 0.05–13271.753 | |||
Health insurance | ||||||
No vs. yes | 0.089 | 0.020 | 0.000–1.811 | |||
Career | ||||||
≦Worker vs. >worker | 0.272 | 27.978 | 0.07–10713.674 | |||
Menopausal status | ||||||
Premenopausal vs. postmenopausal | 0.559 | 0.721 | 0.240–2.160 | |||
Complications | ||||||
With vs. without | 0.125 | 0.309 | 0.069–1.384 | |||
FIGO stags | ||||||
I +II vs. III | 0.002 | 5.652 | 1.892–16.883 | 0.018 | 4.385 | 1.283–14.994 |
Histological grading | ||||||
G1 vs. G2 vs. G3 | 0.001 | 4.514 | 1.896–10.745 | 0.160 | 2.178 | 0.735–6.453 |
Lymph node status | ||||||
Negative vs. positive | <0.001 | 12.232 | 4.196–35.659 | 0.702 | 1.477 | 0.200–10.905 |
Depth of myometrial invasion | ||||||
< 50% vs. ≧50% | <0.001 | 9.745 | 2.713–34.999 | 0.014 | 7.867 | 1.522–40.678 |
HDGF expression | ||||||
Low vs. high | 0.004 | 4.951 | 1.686–14.544 | 0.984 | 0.985 | 0.245–3.964 |
DDX5 expression | ||||||
Low vs. high | <0.001 | 12.126 | 3.209–45.821 | 0.038 | 5.677 | 1.100–29.281 |
Postoperative irradiation | ||||||
Yes vs. no | 0.512 | 1.652 | 0.368–7.409 | |||
Postoperative chemotherapy | ||||||
Yes vs. no | 0.175 | 2.081 | 0.721–6.005 | |||
Postoperative hormone therapy | ||||||
Yes vs. no | 0.044 | 0.267 | 0.074–0.963 | 0.631 | 1.491 | 0.293–7.597 |